Cargando…

Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307369/
https://www.ncbi.nlm.nih.gov/pubmed/37387892
http://dx.doi.org/10.1155/2023/9823465
_version_ 1785066031169929216
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10307369
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103073692023-06-29 Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307369/ /pubmed/37387892 http://dx.doi.org/10.1155/2023/9823465 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section
title Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section
title_full Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section
title_fullStr Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section
title_full_unstemmed Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section
title_short Retracted: The Effectiveness and Safety of Ropivacaine and Medium-Dose Dexmedetomidine in Cesarean Section
title_sort retracted: the effectiveness and safety of ropivacaine and medium-dose dexmedetomidine in cesarean section
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307369/
https://www.ncbi.nlm.nih.gov/pubmed/37387892
http://dx.doi.org/10.1155/2023/9823465
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retractedtheeffectivenessandsafetyofropivacaineandmediumdosedexmedetomidineincesareansection